Neutralizing Type I Interferon Autoantibodies in Japanese Patients with Severe COVID-19
Shohei Eto, Yoko Nukui, Miyuki Tsumura, Yu Nakagama, Kenichi Kashimada, Yoko Mizoguchi, Takanori Utsumi, Maki Taniguchi, Fumiaki Sakura, Kosuke Noma, Yusuke Yoshida, Shinichiro Ohshimo, Shintaro Nagashima, Keisuke Okamoto, Akifumi Endo, Kohsuke Imai, Hirokazu Kanegane, Hidenori Ohnishi, Shintaro Hirata, Eiji Sugiyama, Nobuaki Shime, Masanori Ito, Hiroki Ohge, Yasutoshi Kido, Paul Bastard, Jean‐Laurent Casanova, Osamu Ohara, Junko Tanaka, Tomohiro Morio, Satoshi Okada
Topics & Concepts
AutoantibodyMedicineCoronavirus disease 2019 (COVID-19)ImmunologyPneumoniaPopulationMedical microbiologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Interferon2019-20 coronavirus outbreakVirologyInternal medicineAntibodyDiseaseEnvironmental healthOutbreakInfectious disease (medical specialty)COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchSystemic Lupus Erythematosus Research